In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?

Head Neck. 2021 Apr;43(4):1378-1379. doi: 10.1002/hed.26568. Epub 2020 Dec 9.

Authors

James E Bates¹, Robert J Amdur²

Affiliations

¹ Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
² Department of Radiation Oncology, University of Florida, Gainesville, Florida, USA.

PMID: 33295664
DOI: 10.1002/hed.26568

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Squamous Cell* / therapy
Humans
Oropharyngeal Neoplasms* / therapy
Squamous Cell Carcinoma of Head and Neck